MoldCo
Boston
About MoldCo
MoldCo offers a telehealth platform focused on addressing symptoms and health effects associated with mold exposure and environmental toxins. It connects members with licensed clinicians who conduct diagnostic evaluations via lab testing, biomarker panels, symptom intake questionnaires, and exposure assessments. Treatment plans are customized, often delivered to the member’s home, and include prescription-strength therapies, binders, peptides, and environmental remediation guidance. MoldCo also runs research initiatives to study mold toxicity, identify relevant biomarkers, and refine treatment protocols. The company emphasizes continuous provider support and follow-up throughout a patient’s care journey.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $11.0M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: moldco.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Personal Health, Wellness
Social Profiles
Canonical: https://fsome.com/organization/moldco-103501 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.